Table 1.
Demographic | n (range or %) |
---|---|
Mean Age at Diagnosis (years) | 51.7 (28-78) |
Mean BMI | 32.9 (18-63) |
Mean UELI | 103.6 (73.4-143.3) |
Lymphedema stage | |
Stage 1 lymphedema | 16 (32%) |
Stage 2 lymphedema | 34 (68%) |
Axillary lymph node evaluation | |
ALND | 39 (78%) |
Mean number of ALN | 22 (10-49) |
Median number of ALN | 20 |
Mode number of ALN | 13, 22 |
SNL biopsy | 11 (22%) |
Mean number of SLN | 6 (0-17) |
Median number of SLN | 3 |
Mode number of SLN | 2, 3, 13 |
Radiation | 32 (64%) |
Chemotherapy | 40 (80%) |
Adjuvant | 24 (48%) |
Neoadjuvant | 16 (32%) |
Immediate Reconstruction | 3 (6%) |
Complication | 12 (24%) |
Smoking | |
Never Smoked | 26 (52%) |
Ever Smoked | 24 (48%) |
Comorbidities | |
Hypertension | 17 (34%) |
Dyslipidemia | 9 (18%) |
Diabetes | 4 (8%) |
BMI indicated body mass index; UELI upper extremity lymphedema index; ALND axillary lymph node dissection; SNL sentinel lymph node